[ASND] QoQ Quarter Result on 30-Jun-2017 [#Q2]

Stock
[ASND] Ascendis Pharma A/S
Announcement Date
23-May-2017
Financial Year
2017
Quarter
30-Jun-2017 [#Q2]
Profit Trend
QoQ- -22.14%
YoY- -131.13%
Quarter Report
ASND's Result
ASND's Financial Summary
View:
Show?
Quarter Result
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
Revenue 28 280 434 444 372 1,043 1,169 -91.70%
PBT -41,482 -34,361 -34,117 -30,743 -25,153 -16,426 -18,311 72.57%
Tax -107 -186 -240 -37 -14 22 -57 52.23%
NP -41,375 -34,175 -33,877 -30,706 -25,139 -16,448 -18,254 72.63%
Tax Rate - - - - - - - -
Total Cost 41,403 34,455 34,311 31,150 25,511 17,491 19,423 65.70%
Ratio Analysis
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
NP Margin -147,767.86 -12,205.36 -7,805.76 -6,915.77 -6,757.80 -1,576.99 -1,561.51 1982.38%
Per Share
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
EPS -1.07 -0.92 -1.04 -0.94 -0.78 -0.51 -0.72 30.25%
EPS Diluted -1.07 -0.88 -1.04 -0.94 -0.78 -0.51 -0.72 30.25%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.